Siludi Medicine
Latest round
- Series A
Last raised
- Oct 2020
Total raised
- $145M
Investors
- 4
About Siludi Medicine
Based in Shanghai, China, and established in 2017, Siludi Medicine operates as a biopharmaceutical company that focuses on tumor immunotherapy drug development. The company was split from 3D Medicines Corporation due to business development needs. Siludi Medicine's main business is the research, development, and commercialization of tumor immunotherapy drugs. Its current pipeline consists of two clinical-stage drug candidates, including KN035, a subcutaneously administered PD-L1 antibody, and 3D-185, a selective FGFR-1/2/3 inhibitor. The KN035 was approved for clinical studies by FDA/NMPA/PMDA in 2017.
Who invested in Siludi Medicine
4 investors across 1 round
See all investors in Siludi Medicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 9, 2020
Amount
$145M
Investors
Questions about Siludi Medicine
Who invested in Siludi Medicine?
Siludi Medicine has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Siludi Medicine raised?
Siludi Medicine has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Siludi Medicine last raise money?
Siludi Medicine's most recent round on record is a Series A, in Oct 2020.
What does Siludi Medicine do?
Based in Shanghai, China, and established in 2017, Siludi Medicine operates as a biopharmaceutical company that focuses on tumor immunotherapy drug development.
Where is Siludi Medicine headquartered?
Siludi Medicine is headquartered in Shanghai, China.
Which VCs invest in companies like Siludi Medicine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Siludi Medicine's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Siludi Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.